MEGAMD CO., LTD. Financials MegaMD Co., Ltd.
Equities
A133750
KR7133750000
Miscellaneous Educational Service Providers
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,355 KRW | +1.73% |
|
-0.63% | -5.42% |
| 2023 | MegaMD Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
| 2019 | MegaMD Co., Ltd. completed the acquisition of remaining 48% stake in MDNP Co., Ltd. | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 53,014 | 70,627 | 90,066 | 99,337 | 58,388 | 54,967 |
| Enterprise Value (EV) 1 | 26,199 | 51,393 | 59,464 | 47,132 | 19,714 | 14,648 |
| P/E ratio | 44.9 x | 167 x | 18.3 x | 15 x | 27.6 x | -17.2 x |
| Yield | 2.11% | 1.54% | 2.45% | 3.33% | - | - |
| Capitalization / Revenue | 0.7 x | 0.88 x | 1.09 x | 1.25 x | 0.91 x | 1.53 x |
| EV / Revenue | 0.35 x | 0.64 x | 0.72 x | 0.59 x | 0.31 x | 0.41 x |
| EV / EBITDA | 4.65 x | 4.42 x | 3.05 x | 2.58 x | 1.76 x | 7.43 x |
| EV / FCF | 3.06 x | 5.4 x | 5.32 x | 2.95 x | -2.02 x | -10.9 x |
| FCF Yield | 32.7% | 18.5% | 18.8% | 33.9% | -49.6% | -9.2% |
| Price to Book | 0.86 x | 1.23 x | 1.45 x | 1.49 x | 0.89 x | 0.88 x |
| Nbr of stocks (in thousands) | 22,369 | 21,765 | 22,075 | 22,075 | 22,075 | 22,075 |
| Reference price 2 | 2,370 | 3,245 | 4,080 | 4,500 | 2,645 | 2,490 |
| Announcement Date | 3/14/19 | 3/19/20 | 3/18/21 | 3/23/22 | 3/23/23 | 3/21/24 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 75,328 | 80,374 | 82,440 | 79,435 | 64,468 | 36,041 |
| EBITDA 1 | 5,634 | 11,631 | 19,514 | 18,263 | 11,190 | 1,970 |
| EBIT 1 | 827.3 | -890.6 | 7,345 | 6,487 | 1,918 | -3,939 |
| Operating Margin | 1.1% | -1.11% | 8.91% | 8.17% | 2.97% | -10.93% |
| Earnings before Tax (EBT) 1 | 2,085 | 2,607 | 7,268 | 7,935 | 2,641 | -3,177 |
| Net income 1 | 1,110 | 413.2 | 4,897 | 6,650 | 2,113 | -3,197 |
| Net margin | 1.47% | 0.51% | 5.94% | 8.37% | 3.28% | -8.87% |
| EPS 2 | 52.75 | 19.46 | 223.0 | 300.0 | 95.71 | -145.0 |
| Free Cash Flow 1 | 8,571 | 9,525 | 11,183 | 15,966 | -9,778 | -1,348 |
| FCF margin | 11.38% | 11.85% | 13.57% | 20.1% | -15.17% | -3.74% |
| FCF Conversion (EBITDA) | 152.13% | 81.89% | 57.31% | 87.42% | - | - |
| FCF Conversion (Net income) | 772.45% | 2,304.86% | 228.34% | 240.07% | - | - |
| Dividend per Share 2 | 50.00 | 50.00 | 100.0 | 150.0 | - | - |
| Announcement Date | 3/14/19 | 3/19/20 | 3/18/21 | 3/23/22 | 3/23/23 | 3/21/24 |
1KRW in Million2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 26,814 | 19,235 | 30,602 | 52,205 | 38,674 | 40,319 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | 8,571 | 9,525 | 11,183 | 15,966 | -9,778 | -1,348 |
| ROE (net income / shareholders' equity) | 1.97% | 1.41% | 8.2% | 10.4% | 3.19% | -5% |
| ROA (Net income/ Total Assets) | 0.54% | -0.53% | 4.15% | 3.56% | 1.15% | -2.76% |
| Assets 1 | 207,091 | -77,575 | 118,125 | 186,759 | 183,433 | 115,756 |
| Book Value Per Share 2 | 2,760 | 2,635 | 2,804 | 3,017 | 2,978 | 2,820 |
| Cash Flow per Share 2 | 1,227 | 984.0 | 1,587 | 1,408 | 1,474 | 1,356 |
| Capex 1 | 2,196 | 1,497 | 2,164 | 2,131 | 1,513 | 2,483 |
| Capex / Sales | 2.92% | 1.86% | 2.62% | 2.68% | 2.35% | 6.89% |
| Announcement Date | 3/14/19 | 3/19/20 | 3/18/21 | 3/23/22 | 3/23/23 | 3/21/24 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -5.42% | 38.1M | |
| +19.05% | 14.67B | |
| +3.88% | 8.67B | |
| +9.63% | 4.24B | |
| +20.77% | 3.05B | |
| +28.81% | 2.94B | |
| +18.82% | 2.5B | |
| +11.96% | 2.47B | |
| +114.64% | 2.07B | |
| -0.61% | 1.6B |
- Stock Market
- Equities
- A133750 Stock
- Financials MegaMD Co., Ltd.